{
    "clinical_study": {
        "@rank": "90662", 
        "acronym": "Stripping", 
        "brief_summary": {
            "textblock": "This study aim to estimate maternal and neonatal outcomes after membrane sweeping in\n      different group of patients."
        }, 
        "brief_title": "Maternal and Neonatal Outcomes After Membrane Sweeping", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sepsis", 
            "Infection"
        ], 
        "condition_browse": {
            "mesh_term": "Sepsis"
        }, 
        "detailed_description": {
            "textblock": "Sweeping of the membranes is a simple technique usually performed during vaginal\n      examination, in order to initiate labour by increasing local production of prostaglandins."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women with a singleton pregnancy and confirmed cephalic presentation at or after 37\n             weeks of gestation who are candidate for vaginal delivery were eligible for the study\n\n        Exclusion Criteria:\n\n          -  Women with a multiple pregnancy, nonreassuring cardiotocogram, meconium stained\n             amniotic fluid, major fetal anomalies, HELLP (hemolysis, elevated liver enzymes, and\n             low platelets) syndrome, or severe preeclampsia and signs of intrauterine infections\n             were not eligible.\n\n          -  women who are not candidates for vaginal delivery: placenta previa, breech\n             presentation, planned repeat cesarean."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "17 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All women presenting to the Maternal-fetal unit who are 37+ weeks gestation"
            }
        }, 
        "enrollment": {
            "#text": "1200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01828853", 
            "org_study_id": "Kabiri-Stripping-HMO-CTIL"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Membrane sweeping", 
            "Membrane stripping", 
            "Maternal outcomes", 
            "Neonatal outcomes"
        ], 
        "lastchanged_date": "April 8, 2013", 
        "location": {
            "contact": {
                "email": "doronkabiri@gmail.com", 
                "last_name": "Kabiri"
            }, 
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Hadassah Medical Organization, Jerusalem, Israel"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "Maternal and Neonatal Outcomes After Membrane Sweeping", 
        "overall_contact": {
            "email": "doronkabiri@gmail.com", 
            "last_name": "Doron Kabiri, MD", 
            "phone": "00972-508946898"
        }, 
        "overall_contact_backup": {
            "email": "lhadas@hadassah.org.il", 
            "last_name": "Hadas Lemberg, PhD", 
            "phone": "00 972 2 6777572"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Neonatal sepsis", 
            "safety_issue": "Yes", 
            "time_frame": "Neonates will be followed for the duration of hospital stay, an expected average of 2-3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01828853"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Neonates with two or more of the following signs: Altered behaviour or responsiveness, Altered muscle tone (floppiness), Feeding difficulties, Feed intolerance (vomiting, excessive gastric aspirates, abdominal distension), Abnormal heart rate (bradycardia or tachycardia), Signs of respiratory distress, Hypoxia (central cyanosis or reduced oxygen saturation level), Jaundice, Apnoea, Signs of neonatal encephalopathy, Seizures, Need for cardio-pulmonary resuscitation, Low-temperature (lower than 36\u00b0C), High-temperature (higher than 38\u00b0C), Signs of shock, Unexplained excessive bleeding, thrombocytopenia or abnormal coagulation, Oliguria, Altered glucose homeostasis (hypoglycaemia or hyperglycaemia), Metabolic acidosis, Local signs of infection.", 
            "measure": "Neonatal infection", 
            "safety_issue": "Yes", 
            "time_frame": "Neonates will be followed for the duration of hospital stay, an expected average of 2-3 days"
        }, 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Month", 
        "verification_date": "March 2013"
    }
}